Researchers explored the link between exposure to violence or abuse during childhood and youth/adult asthma in those with high Th2 immunity.

An updated Cochrane Review re-examined outcomes of exercise-based rehabilitation in individuals with pulmonary hypertension.

A clinical trial is assessing the effectiveness of a mandibular advancement device (MAD) as first-line therapy for patients with moderate to severe OSA.

Researchers assessed whether home oscillometry could identify early symptoms of AECOPD, thus preventing acute exacerbations.

How does having Medicare or Medicaid vs private insurance affect the outcomes of patients hospitalized for sarcoidosis?

Researchers surveyed Black and Latinx adults with moderate to severe asthma to determine their preferences with respect to telehealth visits vs in-person asthma care.

Research presented at the AAAAI annual meeting explored whether obesity is a risk factor for fatal or near-fatal events in those experiencing asthma exacerbations.

Investigators characterized the mental health burden experienced by adults with asthma, along with assessing their level of patient satisfaction.

Investigators sought to determine biologic prescription and adherence rates among adults receiving outpatient care for asthma.

A survey presented at AAAAI 2023 assessed clinicians’ awareness and understanding of the NIH/National Heart, Lung, and Blood Institute 2020 updated asthma guidelines.

Researchers assessed the value of the Asthma Impairment and Risk Questionnaire for predicting risk for multiple exacerbations in those with very poorly controlled asthma.

The underlying causes of persistent, unexplained eosinophilia were explored among patients of an inner-city allergy clinic.

Building on research showing greater risk for IHD among women with adult-onset asthma, researchers examined the link between IHD and asthma severity.

A study tested the effects of a COVID-19 Vaccine Allergy Program using skin prick testing and shared decision-making on vaccine-hesitant health care workers.

How well does berotralstat control hereditary angioedema in a real-world population over the course of a year?

Researchers analyzed patients with aspirin-exacerbated respiratory disease to determine the safety and efficacy of a one-day oral aspirin desensitization protocol.

Study authors explored the effect of albuterol/budesonide fixed combination therapy on asthma deterioration and severe asthma exacerbations compared with albuterol, budesonide, or placebo.

How does split dosing of COVID-19 vaccines compare with conventional dosing with respect to antibody responsiveness and safety?

In patients using as-needed short-acting beta2-agonists, how are exacerbations associated with asthma control, maintenance adherence, and disease severity?

A real-world study assessed how pediatric patients with moderate to severe asthma responded to the use dupilumab, mepolizumab, and omalizumab.

How rapid is the onset of effective action when using azelastine HCl 0.15% to relieve nasal symptoms of seasonal allergic rhinitis?

While mepolizumab has proven safe and effective for severe asthma, how has it performed in treating those with allergic vs non-allergic asthma?

Researchers assessed the link between smell loss in CRSwNP and other disease attributes, as well as the effect of dupilumab according to smell loss severity.

What are the most significant predictors of airflow limitation in children 5 to 18 years of age with severe asthma?

Which clinical screening markers predict aspirin-exacerbated respiratory disease in patients with chronic rhinosinusitis with nasal polyps?

How does having atopic dermatitis at 2 years of age affect the risk of developing allergic respiratory disease by 10 years of age?

The phase 3 EPITOPE trial assessed the safety and efficacy of epicutaneous immunotherapy for peanut allergy in children under 4 years old.

Researchers analyzed pooled safety data from 3 clinical trials of lebrikizumab for uncontrolled asthma to determine the drug’s safety profile.

A post hoc analysis of the PATHWAY and NAVIGATOR trials assessed efficacy of tezepelumab in Hispanic/Latino patients with severe, uncontrolled asthma.

Researchers evaluated asthma control in participants receiving maintenance and reliever digital system vs standard maintenance and reliever inhalers.